Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Hallek
Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy
Cell
Biochemistry
Genetics
Molecular Biology
Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 Trial
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Early Treatment With FCR Versus Watch and Wait in Patients With Stage Binet a High-Risk Chronic Lymphocytic Leukemia (CLL): A Randomized Phase 3 Trial
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Cell Line‐based Assessment of BTK Inhibitors
British Journal of Pharmacology
Pharmacology
Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma
Frontiers in Immunology
Allergy
Immunology
Anti-Cd20 Immunotherapy as a Bridge to Tolerance, After Allogeneic Stem Cell Transplantation for Patients With Chronic Lymphocytic Leukaemia: Results of the CLLX4 Trial
British Journal of Haematology
Hematology
Establishing a Chemical Genetic Link Between Bruton Tyrosine Kinase Activity in Malignant B Cells and Cell Functions Involved in the Micro-Environmental Dialogue
British Journal of Haematology
Hematology
Somatic Alterations in Circulating Cell-Free DNA of Oesophageal Carcinoma Patients During Primary Staging Are Indicative for Post-Surgical Tumour Recurrence
Scientific Reports
Multidisciplinary
Obinutuzumab in Chronic Lymphocytic Leukemia: Design, Development and Place in Therapy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
1
2
›